192 related articles for article (PubMed ID: 2121023)
1. Health care policies/economics of the geriatric renal population.
Eggers PW
Am J Kidney Dis; 1990 Oct; 16(4):384-91. PubMed ID: 2121023
[TBL] [Abstract][Full Text] [Related]
2. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
3. A quarter century of medicare expenditures for ESRD.
Eggers PW
Semin Nephrol; 2000 Nov; 20(6):516-22. PubMed ID: 11111852
[TBL] [Abstract][Full Text] [Related]
4. Medicare end stage renal disease population, 1982-87.
Breidenbaugh MZ; Sarsitis IM; Milam RA
Health Care Financ Rev; 1990; 12(1):101-4. PubMed ID: 10113457
[TBL] [Abstract][Full Text] [Related]
5. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S160-77. PubMed ID: 9259700
[No Abstract] [Full Text] [Related]
6. Excluded from universal coverage: ESRD patients not covered by Medicare.
Thamer M; Ray NF; Richard C; Greer JW; Pearson BC; Cotter DJ
Health Care Financ Rev; 1995; 17(2):123-46. PubMed ID: 10157372
[TBL] [Abstract][Full Text] [Related]
7. The organization and financing of kidney dialysis and transplant care in the United States of America.
Hirth RA
Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
[TBL] [Abstract][Full Text] [Related]
8. Financing of end-stage renal disease care: past, present, and future.
Farley DO
Adv Ren Replace Ther; 1994 Apr; 1(1):24-31. PubMed ID: 7641085
[TBL] [Abstract][Full Text] [Related]
9. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.
Xue JL; Ma JZ; Louis TA; Collins AJ
J Am Soc Nephrol; 2001 Dec; 12(12):2753-2758. PubMed ID: 11729245
[TBL] [Abstract][Full Text] [Related]
10. Medicare program; clarification of resumption of entitlement rules for Medicare patients with end-stage renal disease (ESRD)--HCFA. Final rule.
Fed Regist; 1995 May; 60(88 Pt 1):22533-5. PubMed ID: 10142805
[TBL] [Abstract][Full Text] [Related]
11. The use of Health Care Financing Administration data for the development of a quality improvement project on the treatment of anemia.
Eggers PW; Greer J; Jencks S
Am J Kidney Dis; 1994 Aug; 24(2):247-54. PubMed ID: 8048432
[TBL] [Abstract][Full Text] [Related]
12. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of end stage renal disease and implications for public policy.
Rubin RJ
Public Health Rep; 1984; 99(5):492-8. PubMed ID: 6435162
[TBL] [Abstract][Full Text] [Related]
14. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
[TBL] [Abstract][Full Text] [Related]
15. End stage renal disease.
Greer J
Health Care Financ Rev Annu Suppl; 1992; ():199-205. PubMed ID: 10131707
[No Abstract] [Full Text] [Related]
16. The dilemmas of patient treatment for end-stage renal disease.
Schmidt RW; Blumenkrantz M; Wiegmann TB
Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
[TBL] [Abstract][Full Text] [Related]
17. The Role of Big Data in the Development and Evaluation of US Dialysis Care.
Erickson KF; Qureshi S; Winkelmayer WC
Am J Kidney Dis; 2018 Oct; 72(4):560-568. PubMed ID: 29921451
[TBL] [Abstract][Full Text] [Related]
18. Patient selection in the Medicare End-Stage Renal Disease Program.
de Lissovoy G
Med Care; 1988 Oct; 26(10):959-70. PubMed ID: 3139942
[TBL] [Abstract][Full Text] [Related]
19. Medicare's ESRD Program, Part 1: Dialysis.
Long HW
Physician Exec; 1989; 15(2):24-6. PubMed ID: 10313034
[TBL] [Abstract][Full Text] [Related]
20. Projecting the United States ESRD population: issues regarding treatment of patients with ESRD.
Szczech LA; Lazar IL
Kidney Int Suppl; 2004 Sep; (90):S3-7. PubMed ID: 15296500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
